Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Application for the Canada Graduate Scholarships - Master's Program
FY 2020-21
Summary
Introduction In 2014, we identified UM171, a small molecule, that enables expansion of human hematopoietic stem and progenitor cells. Interestingly in a clinical trial using UM171, Cohen et al. reported a lower incidence of severe acute Graft-Versus-Host-Disease (GVHD) for UM171-expanded grafts compared to unmanipulated cord blood (CB). In allo-HSCT-induced GVHD, alloreactive activation of the donor T cells also depends on a variety of innate immune cells. As such, the main objective of this study is to investigate which immune population(s) present in UM171-expanded grafts confers protective effects in preventing the development of acute GVHD in a GVHD xenotransplantation model.Detailed Objectives 1. Characterization of UM171-expanded innate immune cell populations and their progeny. a. Phenotypical characterization by flow cytometry using well known markers of immune cells. b. Transcriptomic characterization using bulk transcriptome, single cell sequencing and Cite-seq (Cellular Indexing of Transcriptomes and Epitopes by sequencing) based analysis. 2. Functionally identify which population confers GVHD protecting effect in vivo. a. Establishment of a xenograft GVHD model using NSG-3SGM mice. b. Sort immune cells characterized in objective 1 and test their ability to reduce GVHD in xenotransplantation model. Conclusion The potential findings of this study will help design therapeutic strategies involving the ex vivo expansion of GVHD-protective populations which could be administered during CB transplantation. Ultimately, these strategies could help improve the outcome of CB transplantation by decreasing transplant-related mortality.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449821
Name
Maalaoui Hana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Application for the Canada Graduate Scholarships - Master's Program
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioluminescence; Cord Blood; Flow Cytometry; Graft-Versus-Host-Disease; Human Stem And Progenitors Cells; Immune Cells; Murine; Single Cell Sequencing; Um171; Xenotransplantation
Abstract
Introduction In 2014, we identified UM171, a small molecule, that enables expansion of human hematopoietic stem and progenitor cells. Interestingly in a clinical trial using UM171, Cohen et al. reported a lower incidence of severe acute Graft-Versus-Host-Disease (GVHD) for UM171-expanded grafts compared to unmanipulated cord blood (CB). In allo-HSCT-induced GVHD, alloreactive activation of the donor T cells also depends on a variety of innate immune cells. As such, the main objective of this study is to investigate which immune population(s) present in UM171-expanded grafts confers protective effects in preventing the development of acute GVHD in a GVHD xenotransplantation model.Detailed Objectives 1. Characterization of UM171-expanded innate immune cell populations and their progeny. a. Phenotypical characterization by flow cytometry using well known markers of immune cells. b. Transcriptomic characterization using bulk transcriptome, single cell sequencing and Cite-seq (Cellular Indexing of Transcriptomes and Epitopes by sequencing) based analysis. 2. Functionally identify which population confers GVHD protecting effect in vivo. a. Establishment of a xenograft GVHD model using NSG-3SGM mice. b. Sort immune cells characterized in objective 1 and test their ability to reduce GVHD in xenotransplantation model. Conclusion The potential findings of this study will help design therapeutic strategies involving the ex vivo expansion of GVHD-protective populations which could be administered during CB transplantation. Ultimately, these strategies could help improve the outcome of CB transplantation by decreasing transplant-related mortality.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Maalaoui, Hana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~